Molecular Mechanisms Underlying Diamond-Blackfan Anemia and Other Congenital Bone Marrow Failure Syndromes
The summary for the Molecular Mechanisms Underlying Diamond-Blackfan Anemia and Other Congenital Bone Marrow Failure Syndromes grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Molecular Mechanisms Underlying Diamond-Blackfan Anemia and Other Congenital Bone Marrow Failure Syndromes: The goal of this initiative is to encourage research into the genetics and basic mechanisms of Diamond-Blackfan Anemia and other rare inherited bone marrow failure syndromes that have received little attention from the research community. Applications are sought that propose innovative research approaches to understand the molecular pathways disrupted in these syndromes. The bone marrow failure syndromes covered by this initiative include: Diamond-Blackfan anemia, dyskeratosis congenita, Pearson syndrome, severe congenital neutropenia (Kostmann syndrome), Shwachman-Diamond syndrome, and congenital amegakaryocytic thrombocytopenia.
|Federal Grant Title:||Molecular Mechanisms Underlying Diamond-Blackfan Anemia and Other Congenital Bone Marrow Failure Syndromes|
|Federal Agency Name:||National Institutes of Health|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||RFA-HL-04-008|
|Type of Funding:||Grant|
|CFDA Descriptions:||Blood Diseases and Resources Research|
|Current Application Deadline:||No deadline provided|
|Original Application Deadline:||Mar 17, 2004|
|Posted Date:||Sep 23, 2003|
|Creation Date:||Apr 16, 2004|
|Archive Date:||Apr 16, 2004|
|Total Program Funding:|
|Maximum Federal Grant Award:|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
- Similar Government Grants
- • Sex Hormone Induced Thromboembolism in Pre-Menopausal Women (R61/R33)
- • Perinatal Stroke (R01)
- • Selected Topics in Transfusion Medicine (R01)
- • Selected Topics in Transfusion Medicine (R21)
- • Advancing Erythroid Cell Biology (R01)
- • Improved Therapy for Hemophilia and Hereditary Bleeding Disorders
- • Clinical Hematology Research Career Development Program (K12)
- • Specialized Centers of Clinically Oriented Research (Sccor) in Transfusion Biology and Med...
- More Grants from the National Institutes of Health
- • Limited Competition for NIH-Industry Program: Discovering Pediatric New Therapeutic Uses f...
- • Environmental influences on Placental Origins of Development (ePOD) (R01)
- • Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existin...
- • Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existin...
- • Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01)